Uric Acid in vitro diagnostic test REF: 31H0P Recall

Ongoing
Medical Devices
Class II — Moderate

Recall Date

May 13, 2026

Company

DFI Co., Ltd.

Source

FDA

Units

59815 units

Reason: The devices were distributed without required FDA premarket clearance or approval.

Class II: Use of the product may cause temporary or medically reversible health problems.

Official FDA recall notice

Information is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.

Recall Details

Description

The devices were distributed without required FDA premarket clearance or approval.

Reason for Recall

The devices were distributed without required FDA premarket clearance or approval.

Product: Uric Acid in vitro diagnostic test REF: 31H0P
Official Recall ID: FDA-DEV-Z-2086-2026
Units affected: 59815 units

What Should I Do?

Check the model/lot number and contact your healthcare provider or the manufacturer.

Quantity: 59815 units

Remediation GuideAction Required

5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.

1
Confirm Your Product Is Affected
2
Read the Full Recall Notice
3
Stop Using the Product if in Doubt

+2 more steps…

View Official Recall Notice (FDA)

Last updated May 19, 2026

All affected products in this recall
  • One Step K in vitro diagnostic test REF: 81A4 · ID FDA-DEV-Z-2087-2026 · 761 units units
  • Uric Acid in vitro diagnostic test REF: 31H0P · ID FDA-DEV-Z-2086-2026 · 59815 units units

Injured by a recalled product?

Our legal partners offer free consultations for recall victims.

Get Free Legal Help →Sponsored

Stay Informed

Weekly recall digest — free, no spam.